| Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada C Sauvageau, B Duval, V Gilca, F Lavoie, M Ouakki BMC Public Health 7, 1-6, 2007 | 165 | 2007 |
| Parents’ decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results A Krawczyk, B Knäuper, V Gilca, E Dubé, S Perez, K Joyal-Desmarais, ... Human vaccines & immunotherapeutics 11 (2), 322-329, 2015 | 114 | 2015 |
| Cervical cancer prevention by vaccination: nurses’ knowledge, attitudes and intentions B Duval, V Gilca, N Boulianne, K Pielak, B Halperin, MA Simpson, ... Journal of advanced nursing 65 (3), 499-508, 2009 | 111 | 2009 |
| Protection against omicron (B. 1.1. 529) BA. 2 reinfection conferred by primary omicron BA. 1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without … S Carazo, DM Skowronski, M Brisson, S Barkati, C Sauvageau, ... The Lancet Infectious Diseases 23 (1), 45-55, 2023 | 105 | 2023 |
| Vaccination against human papillomavirus: a baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs B Duval, V Gilca, S McNeil, S Dobson, D Money, IM Gemmill, ... Vaccine 25 (45), 7841-7847, 2007 | 105 | 2007 |
| Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v) DM Skowronski, NZ Janjua, G De Serres, D Purych, V Gilca, ... The Journal of infectious diseases 206 (12), 1852-1861, 2012 | 103 | 2012 |
| Determinants of parents’ decision to vaccinate their children against rotavirus: results of a longitudinal study E Dubé, JA Bettinger, B Halperin, R Bradet, F Lavoie, C Sauvageau, ... Health education research 27 (6), 1069-1080, 2012 | 96 | 2012 |
| Impact of an immunization campaign to control an increased incidence of serogroup B meningococcal disease in one region of Quebec, Canada P De Wals, G Deceuninck, B Lefebvre, R Tsang, D Law, G De Serres, ... Clinical infectious diseases 64 (9), 1263-1267, 2017 | 86 | 2017 |
| Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies AM Anonychuk, AC Tricco, CT Bauch, B Pham, V Gilca, B Duval, ... Pharmacoeconomics 26, 17-32, 2008 | 86 | 2008 |
| Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country B Duval, V Gîlca, N Boulianne, P De Wals, R Massé, G Trudeau, ... The Pediatric infectious disease journal 24 (3), 213-218, 2005 | 82 | 2005 |
| Cost-utility of universal hepatitis A vaccination in Canada CT Bauch, AM Anonychuk, BZ Pham, V Gilca, B Duval, MD Krahn Vaccine 25 (51), 8536-8548, 2007 | 75 | 2007 |
| Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review B Pham, B Duval, G De Serres, V Gilca, AC Tricco, J Ochnio, ... BMC Infectious diseases 5, 1-11, 2005 | 62 | 2005 |
| Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine V Gilca, G De Serres, N Boulianne, D Murphy, P De Wals, M Ouakki, ... Vaccine 31 (3), 448-451, 2013 | 61 | 2013 |
| Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis AC Tricco, CH Ng, V Gilca, A Anonychuk, B Pham, S Berliner BMC infectious diseases 11, 1-15, 2011 | 59 | 2011 |
| Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A (H1N1) pandemic vaccine E Dubé, V Gilca, C Sauvageau, N Boulianne, FD Boucher, JA Bettinger, ... BMC Research Notes 3, 1-5, 2010 | 56 | 2010 |
| Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal … S Perez, O Tatar, GK Shapiro, E Dubé, G Ogilvie, J Guichon, V Gilca, ... BMC Public Health 16, 1-17, 2016 | 54 | 2016 |
| Estimated protection of prior SARS-CoV-2 infection against reinfection with the Omicron variant among messenger RNA–vaccinated and nonvaccinated individuals in Quebec, Canada S Carazo, DM Skowronski, M Brisson, C Sauvageau, N Brousseau, ... JAMA network open 5 (10), e2236670-e2236670, 2022 | 52 | 2022 |
| Attitudes of nurses toward current and proposed vaccines for public programs: a questionnaire survey V Gilca, N Boulianne, E Dubé, C Sauvageau, M Ouakki International Journal of Nursing Studies 46 (9), 1219-1235, 2009 | 52 | 2009 |
| Burden of acute otitis media on Canadian families E Dubé, P De Wals, V Gilca, N Boulianne, M Ouakki, F Lavoie, R Bradet Canadian Family Physician 57 (1), 60-65, 2011 | 50 | 2011 |
| Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children V Gilca, G De Serres, ME Hamelin, G Boivin, M Ouakki, N Boulianne, ... Vaccine 30 (1), 35-41, 2011 | 49 | 2011 |
